Purpose

This research trial studies the use of clinical practice guidelines by pediatric oncology healthcare providers in order to identify, understand, and overcome barriers to them. The treatments for childhood cancers are intense and result in a high rate of symptoms which require support by healthcare providers. By reviewing patients' medical chart records, meeting in focus groups and in one-on-one interviews, healthcare providers may improve how clinical practice guidelines are used to support children undergoing cancer treatment.

Conditions

Eligibility

Eligible Ages
Under 20 Years
Eligible Genders
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Site willingness to participate in all 3 aims
  • AIM 1 - ELIGIBILITY CRITERIA FOR INCLUSION IN RETROSPECTIVE CENTRALIZED CHART REVIEW
  • Received care as an inpatient or outpatient at a participating COG NCORP site during the time period between January 1, 2014 and December 31, 2015
  • Ever enrolled on any COG trial (episode does not have to occur while on trial and the COG trial may be therapeutic or non-therapeutic)
  • Has at least one episode eligible for FN, CINV or FP review
  • CPG-Specific Eligibility
  • FN
  • Has any of the following diagnoses:
  • Newly diagnosed acute lymphoblastic leukemia
  • Relapsed acute lymphoblastic leukemia
  • Any acute myeloid leukemia
  • Burkitt's or mature B cell non-Hodgkin's lymphoma
  • Any myeloablative autologous or allogeneic hematopoietic stem cell transplantation
  • Developed FN at least once
  • CINV
  • Diagnosis of cancer
  • Received moderately emetogenic chemotherapy as an inpatient
  • < 12 years of age at the start of a CINV episode and received highly emetogenic chemotherapy as an in-patient
  • FP
  • Newly diagnosed cancer
  • >= 15 years of age at cancer diagnosis
  • Note: a single patient may contribute data for multiple episodes
  • AIM 2 AND AIM 3 INCLUSION CRITERIA
  • Healthcare professional currently employed at a participating COG NCORP institution
  • Eligible healthcare providers include but are not limited to: physicians, nurses, nurse practitioners, pharmacists, social workers, dieticians, psychologists, and physical therapists/physiotherapists
  • Provides direct care for children with cancer as part of current position at NCORP site

Exclusion Criteria

  • AIM 2 AND AIM 3 EXCLUSION CRITERIA
  • Trainees are excluded
  • Previous participation in this study either for Aim 2 or Aim 3
  • Each health care provider can only be involved in one event (focus group or interview)

Study Design

Phase
Study Type
Observational
Observational Model
Case-Only
Time Perspective
Retrospective

Arm Groups

ArmDescriptionAssigned Intervention
Observational (chart review, focus group, interviews) AIM 1 (CHART REVIEW): Patients are separated for each CPG evaluated (fever and neutropenia [FN], chemotherapy induced nausea and vomiting [CINV], fertility preservation [FP]) and are randomly selected for medical chart review. Patients with eligible episodes of FN, CINV or FP within the health records are selected and have the data from their records abstracted and reviewed by COG for adherence to COG endorsed CPGs. AIM 2 (FOCUS GROUPS): Health care providers who provide direct care to pediatric oncology patients are identified and separated to participate in three types of focus groups: physician-only, non-physician, and mixed. AIM 3 (INTERVIEWS): Health care providers undergo one-on-one interviews consisting of think aloud technique (TAL) of cognitive interviewing.
  • Other: Informational Intervention
    Participate in focus group
  • Other: Interview
    Undergo one-on-one interviews
  • Other: Medical Chart Review
    Review of medical chart
    Other names:
    • Chart Review
  • Other: Questionnaire Administration
    Ancillary studies

Recruiting Locations

Montefiore Medical Center - Moses Campus
Bronx, New York 10467
Contact:
Site Public Contact
718-379-6866
aaraiza@montefiore.org

More Details

Status
Recruiting
Sponsor
Children's Oncology Group

Study Contact

Detailed Description

PRIMARY OBJECTIVES:

I. To measure the rate of adherence to selected Children's Oncology Group (COG)-endorsed supportive care clinical practice guidelines (CPG) recommendations at National Cancer Institute (NCI) Community Oncology Research Program (NCORP) sites. (Aim 1) II. To describe the possible influence of NCORP site size and the number of patients enrolled in COG studies per site on the delivery of CPG-consistent care. (Aim 1a) III. To describe the clinical outcome of episodes during which patients receive CPG-consistent or CPG-inconsistent care. (Aim 1b) IV. To describe facilitators of and barriers to the use of CPGs elicited via focus group interviews with a diverse set of potential users (physician, nurse, nurse practitioner and pharmacists) who provide pediatric cancer care at NCORP sites. (Aim 2) V. To improve how well CPG recommendations are understood by health care providers by refining the CPG recommendation format based on an iterative process of cognitive interviewing and formatting revisions. (Aim 3)

OUTLINE:

AIM 1 (CHART REVIEW): Patients are separated for each CPG evaluated (fever and neutropenia [FN], chemotherapy induced nausea and vomiting [CINV], fertility preservation [FP]) and are randomly selected for medical chart review. Patients with eligible episodes of FN, CINV or FP within the health records are selected and have the data from their records abstracted and reviewed by COG for adherence to COG endorsed CPGs.

AIM 2 (FOCUS GROUPS): Health care providers who provide direct care to pediatric oncology patients are identified and separated to participate in three types of focus groups: physician-only, non-physician, and mixed.

AIM 3 (INTERVIEWS): Health care providers undergo one-on-one interviews consisting of think aloud technique (TAL) of cognitive interviewing.

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.